CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 152 enrolled
Drug / intervention
Collection of data from the patient's medical fileother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06365268
NCT06365268N/ACompleted

Perinatal Thoraco-abdominal Tumors Management in Infants : a Multicenter Experience

Assistance Publique - Hôpitaux de Paris·observational·Posted Apr 15, 2024·Updated Sep 19, 2025

In Brief

An observational study evaluating Collection of data from the patient's medical file for Perinatal Solid Tumors of the Thoraco-abdomino-pelvic Region. Completed, enrolled 152 participants across 5 sites.

Detailed Summary

Congenital tumors are a rare diagnosis in the fetus and newborn. They differ from those of children and adults in terms of the nature, location and evolution of the tumor. Indeed, some histologically benign tumors may have lethal potential in utero (e.g. sacrococcygeal teratomas) or even undergo malignant transformation if left untreated. In contrast, other tumors that are malignant by histological criteria may have a very good prognosis, regressing spontaneously within the first year of life (e.g. neuroblastoma). Despite advances in imaging, benign and malignant solid tumors remain a major diagnostic and prognostic challenge in the antenatal context. The management of congenital tumors requires multidisciplinary expertise, taking into account the perinatal context, which poses specific problems, particularly in terms of therapeutic aspects, but also the frequent existence of associated malformations and/or genetic predisposition syndromes. This study focuses on solid tumors of the thoraco-abdomino-pelvic region, the main objective being to investigate the correlation between antenatal clinical and radiological analysis and confirmed postnatal diagnosis of congenital solid truncal tumors, as well as the developmental spectrum in which they fit.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance

Timeline

N/ACompletedFinished
20252026
First PostedApr 15, 2024
Enrollment StartSep 5, 2024
Primary CompletionOct 10, 2024
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 2.2 years ago

Interventions

Collection of data from the patient's medical fileother

Collection of data from the patient's medical file. The data collected concerns a period of three years maximum.